CYTOKINETICS, INCORPORATED (CYTK)

SEC filing

CYTOKINETICS, INCORPORATED

CYTK · CIK 1061983

4 · Sep 22, 2026 · EVP Research & Development Malik Fady Ibraham sold 3,500 shares at $68.29/share ($239.0K); exercised options for 7,000 shares

EVP Research & Development Malik Fady Ibraham sold 3,500 shares at $68.29/share ($239.0K); exercised options for 7,000 shares

PRIMARY DOCUMENT

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).